SEC Filing Details
Document Details
Form
Filing Date
February 01, 2024
Document Date
January 30, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Enliven Therapeutics
Issuer
ENLIVEN THERAPEUTICS, INC.
Filer
Heyman Richard A.